日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Persistence of Cross-Reactive Immunity to Influenza B/Yamagata Neuraminidase Despite the Disappearance of the Lineage: Structural and Serological Evidence.

尽管流感B/山形神经氨酸酶谱系消失,但交叉反应免疫仍然存在:结构和血清学证据

Desheva Yulia, Kudar Polina, Sergeeva Maria, Wong Pei-Fong, Shvedova Tamara, Bazhenova Ekaterina, Krylova Evelyna, Kurpiaeva Maria, Romanovskaya-Romanko Ekaterina, Krivitskaya Vera, Kudria Kira, Isakova-Sivak Irina, Stukova Marina

A highly divergent sample from a nearly extinct SARS-CoV-2 lineage in a patient with long-term COVID-19

在一名长期新冠肺炎患者体内发现的样本,与几乎灭绝的SARS-CoV-2谱系高度不同。

Nabieva, Elena; Klink, Galya V; Komissarov, Andrey B; Zaitsev, Stanislav V; Sergeeva, Maria; Fadeev, Artem V; Komissarova, Kseniya; Ivanova, Anna; Pisareva, Maria; Kudrya, Kira; Danilenko, Daria; Lioznov, Dmitry; Hisner, Ryan; Gueli, Federico; Peacock, Thomas P; Roemer, Cornelius; Bazykin, Georgii A

A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants

一种强效、广谱中和的人类单克隆抗体,可有效保护hACE2转基因小鼠免受武汉、BA.5和XBB.1.5 SARS-CoV-2变种的感染。

Guselnikov, Sergey V; Baranov, Konstantin O; Kulemzin, Sergey V; Belovezhets, Tatyana N; Chikaev, Anton N; Murasheva, Svetlana V; Volkova, Olga Y; Mechetina, Ludmila V; Najakshin, Alexander M; Chikaev, Nikolai A; Solodkov, Pavel P; Sergeeva, Maria V; Smirnov, Alexander V; Serova, Irina A; Serov, Oleg L; Markhaev, Alexander G; Kononova, Yulia V; Alekseev, Alexander Y; Gulyaeva, Marina A; Danilenko, Daria M; Battulin, Nariman R; Shestopalov, Alexander M; Taranin, Alexander V

Neuraminidase Antibody Response to Homologous and Drifted Influenza A Viruses After Immunization with Seasonal Influenza Vaccines

接种季节性流感疫苗后,针对同源和漂移的甲型流感病毒的神经氨酸酶抗体反应

Desheva, Yulia; Sergeeva, Maria; Kudar, Polina; Rekstin, Andrey; Romanovskaya-Romanko, Ekaterina; Krivitskaya, Vera; Kudria, Kira; Bazhenova, Ekaterina; Stepanova, Ekaterina; Krylova, Evelina; Kurpiaeva, Maria; Lioznov, Dmitry; Stukova, Marina; Kiseleva, Irina

Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up

一项针对健康成年人的灭活全病毒疫苗 QazCovid-in® 的有效性和安全性:一项多中心、随机、单盲、安慰剂对照的 3 期临床试验,随访时间为 6 个月

Khairullin, Berik; Zakarya, Kunsulu; Orynbayev, Mukhit; Abduraimov, Yergali; Kassenov, Markhabat; Sarsenbayeva, Gulbanu; Sultankulova, Kulyaisan; Chervyakova, Olga; Myrzakhmetova, Balzhan; Nakhanov, Aziz; Nurpeisova, Ainur; Zhugunissov, Kuandyk; Assanzhanova, Nurika; Nurabayev, Sergazy; Kerimbayev, Aslan; Yershebulov, Zakir; Burashev, Yerbol; Kulmagambetov, Ilyas; Davlyatshin, Timur; Sergeeva, Maria; Buzitskaya, Zhanna; Stukova, Marina; Kutumbetov, Lespek

Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization

含有SARS-CoV-2刺突蛋白受体结合域短构象表位的杂交蛋白在用于免疫接种时可促进病毒中和抗体的产生

Karyagina, Anna S; Gromov, Alexander V; Grunina, Tatyana M; Lyaschuk, Alexander M; Poponova, Maria S; Kleymenov, Denis A; Strukova, Natalia V; Generalova, Maria S; Ryazanova, Anna V; Galushkina, Zoya M; Dobrynina, Olga Yu; Bolshakova, Tatyana N; Sergeeva, Maria V; Romanovskaya-Romanko, Ekaterina A; Krasilnikov, Igor V; Subbotina, Marina E; Lunin, Vladimir G

Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan

QazCovid-in®灭活全病毒疫苗在健康成人中的安全性和免疫原性:一项在哈萨克斯坦开展的单中心、随机、单盲、安慰剂对照的1期临床试验和一项为期6个月的开放标签2期临床试验

Zakarya, Kunsulu; Kutumbetov, Lespek; Orynbayev, Mukhit; Abduraimov, Yergali; Sultankulova, Kulyaisan; Kassenov, Markhabat; Sarsenbayeva, Gulbanu; Kulmagambetov, Ilyas; Davlyatshin, Timur; Sergeeva, Maria; Stukova, Marina; Khairullin, Berik

Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs

鼻内接种编码截短NS1蛋白的甲型流感病毒可通过抑制肺部炎症反应来保护小鼠免受异源攻击。

Vasilyev, Kirill; Shurygina, Anna-Polina; Sergeeva, Maria; Stukova, Marina; Egorov, Andrej

Rapid spread of influenza A(H1N1)pdm09 viruses with a new set of specific mutations in the internal genes in the beginning of 2015/2016 epidemic season in Moscow and Saint Petersburg (Russian Federation)

2015/2016 年流感流行季初期,在莫斯科和圣彼得堡(俄罗斯联邦)出现了甲型 H1N1 流感病毒(pdm09)的快速传播,该病毒的内部基因发生了一系列新的特定突变。

Komissarov, Andrey; Fadeev, Artem; Sergeeva, Maria; Petrov, Sergey; Sintsova, Kseniya; Egorova, Anna; Pisareva, Maria; Buzitskaya, Zhanna; Musaeva, Tamila; Danilenko, Daria; Konovalova, Nadezhda; Petrova, Polina; Stolyarov, Kirill; Smorodintseva, Elizaveta; Burtseva, Elena; Krasnoslobodtsev, Kirill; Kirillova, Elena; Karpova, Lyudmila; Eropkin, Mikhail; Sominina, Anna; Grudinin, Mikhail

An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans

一种灭活的、佐剂化的全病毒体2.2分支H5N1(A/Chicken/Astana/6/05)流感疫苗,在人体单剂接种后安全且具有免疫原性。

Sansyzbay, Abylay R; Erofeeva, Marianna K; Khairullin, Berik M; Sandybayev, Nurlan T; Kydyrbayev, Zhailaubay K; Mamadaliyev, Seidigapbar M; Kassenov, Markhabat M; Sergeeva, Maria V; Romanova, Julia R; Krivitskaya, Vera Z; Kiselev, Oleg I; Stukova, Marina A